Stocks
BioMarin Pharmaceutical Inc.BMRN
NASDAQHealthcareBiotechnology$58.51-0.95%
Specializing in rare genetic diseases, this biopharmaceutical firm develops and commercializes therapies for conditions with high unmet medical needs. Investors monitor BioMarin for its pipeline of enzyme replacement therapies and gene-targeted treatments, which command premium pricing in niche markets.
Market Cap: $11.3B52W Range: $50.76 – $73.18
Congressional Interest in BioMarin Pharmaceutical Inc. (BMRN)
10 members of Congress have disclosed 24 trades in BioMarin Pharmaceutical Inc. (BMRN), a Healthcare company. The buy/sell breakdown shows 12 purchases versus 12 sales. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
24
Unique Politicians
10
Buys
12
Sells
12
Who in Congress Is Trading BMRN?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-03-06 | Daniel Goldman | sell | $1K – $15K |
| 2022-05-09 | Rohit Khanna | sell | $1K – $15K |